These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 11792148
1. Vascular endothelial growth factor is increased in ascites from metastatic pancreatic cancer. Liu CD, Tilch L, Kwan D, McFadden DW. J Surg Res; 2002 Jan; 102(1):31-4. PubMed ID: 11792148 [Abstract] [Full Text] [Related]
2. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G. Cancer; 1999 Jan 01; 85(1):178-87. PubMed ID: 9921991 [Abstract] [Full Text] [Related]
3. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors. Luo JC, Yamaguchi S, Shinkai A, Shitara K, Shibuya M. Cancer Res; 1998 Jun 15; 58(12):2652-60. PubMed ID: 9635593 [Abstract] [Full Text] [Related]
4. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody. Luo JC, Toyoda M, Shibuya M. Cancer Res; 1998 Jun 15; 58(12):2594-600. PubMed ID: 9635584 [Abstract] [Full Text] [Related]
5. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines. Fukasawa M, Korc M. Clin Cancer Res; 2004 May 15; 10(10):3327-32. PubMed ID: 15161686 [Abstract] [Full Text] [Related]
7. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K, Noguchi M. Oncol Rep; 2003 Feb 15; 10(1):89-95. PubMed ID: 12469150 [Abstract] [Full Text] [Related]
8. Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Yeo KT, Wang HH, Nagy JA, Sioussat TM, Ledbetter SR, Hoogewerf AJ, Zhou Y, Masse EM, Senger DR, Dvorak HF. Cancer Res; 1993 Jun 15; 53(12):2912-8. PubMed ID: 8504432 [Abstract] [Full Text] [Related]
9. Pathogenesis of ascites tumor growth: vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Nagy JA, Masse EM, Herzberg KT, Meyers MS, Yeo KT, Yeo TK, Sioussat TM, Dvorak HF. Cancer Res; 1995 Jan 15; 55(2):360-8. PubMed ID: 7812969 [Abstract] [Full Text] [Related]
10. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Itakura J, Ishiwata T, Friess H, Fujii H, Matsumoto Y, Büchler MW, Korc M. Clin Cancer Res; 1997 Aug 15; 3(8):1309-16. PubMed ID: 9815813 [Abstract] [Full Text] [Related]
12. Suppression of primary tumor growth in a mouse model of human neuroblastoma. Rowe DH, Huang J, Li J, Manley C, O'Toole KM, Stolar CJ, Yamashiro DJ, Kandel JJ. J Pediatr Surg; 2000 Jun 15; 35(6):977-81. PubMed ID: 10873048 [Abstract] [Full Text] [Related]
13. Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice. Pourgholami MH, Yan Cai Z, Lu Y, Wang L, Morris DL. Clin Cancer Res; 2006 Mar 15; 12(6):1928-35. PubMed ID: 16551879 [Abstract] [Full Text] [Related]
14. Angiogenic protein expression in advanced epithelial ovarian cancer. Barton DP, Cai A, Wendt K, Young M, Gamero A, De Cesare S. Clin Cancer Res; 1997 Sep 15; 3(9):1579-86. PubMed ID: 9815846 [Abstract] [Full Text] [Related]
15. Differential vascular and transcriptional responses to anti-vascular endothelial growth factor antibody in orthotopic human pancreatic cancer xenografts. Bockhorn M, Tsuzuki Y, Xu L, Frilling A, Broelsch CE, Fukumura D. Clin Cancer Res; 2003 Sep 15; 9(11):4221-6. PubMed ID: 14519649 [Abstract] [Full Text] [Related]
16. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Deryugina EI, Soroceanu L, Strongin AY. Cancer Res; 2002 Jan 15; 62(2):580-8. PubMed ID: 11809713 [Abstract] [Full Text] [Related]
17. Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions. Zebrowski BK, Yano S, Liu W, Shaheen RM, Hicklin DJ, Putnam JB, Ellis LM. Clin Cancer Res; 1999 Nov 15; 5(11):3364-8. PubMed ID: 10589746 [Abstract] [Full Text] [Related]
18. Relationship between vessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in small cell lung cancer in vivo and in vitro. Lund EL, Thorsen C, Pedersen MW, Junker N, Kristjansen PE. Clin Cancer Res; 2000 Nov 15; 6(11):4287-91. PubMed ID: 11106245 [Abstract] [Full Text] [Related]
19. Selective blockade of vascular endothelial growth factor receptor 2 with an antibody against tumor-derived vascular endothelial growth factor controls the growth of human pancreatic adenocarcinoma xenografts. Holloway SE, Beck AW, Shivakumar L, Shih J, Fleming JB, Brekken RA. Ann Surg Oncol; 2006 Aug 15; 13(8):1145-55. PubMed ID: 16791450 [Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Barbera-Guillem E, Nyhus JK, Wolford CC, Friece CR, Sampsel JW. Cancer Res; 2002 Dec 01; 62(23):7042-9. PubMed ID: 12460925 [Abstract] [Full Text] [Related] Page: [Next] [New Search]